title: Reply: To PMID 26164828.
authors.affiliation: Créteil, France.
authors.forename: Elsa
authors.initials: E
authors.lastname: Bruyère
authors.affiliation: Créteil, France.
authors.forename: Violaine
authors.initials: V
authors.lastname: Caillaux
authors.affiliation: Créteil, France.
authors.forename: Salomon Yves
authors.initials: SY
authors.lastname: Cohen
authors.affiliation: Créteil, France.
authors.forename: David
authors.initials: D
authors.lastname: Martiano
authors.affiliation: Créteil, France.
authors.forename: Raphaelle
authors.initials: R
authors.lastname: Ores
authors.affiliation: Créteil, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Puche
authors.affiliation: Créteil, France.
authors.forename: Eric H
authors.initials: EH
authors.lastname: Souied
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D047728:Myopia, Degenerative / Q000503:physiopathology*; D058471:Subretinal Fluid / Q000502:physiology*; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A